Product Images Brineura
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 11 images provide visual information about the product associated with Brineura NDC 68135-811 by Biomarin Pharmaceutical Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1 - brineura 1
Intraventricular Electrolytes Injection Vial - brineura 10
Admin Kit - brineura 11
Figure 2 - brineura 2
Figure 3 - brineura 3
Figure 4 - brineura 4
Figure 5 - brineura 5
Figure 6 - brineura 6
Figure 7 - brineura 7
Carton - brineura 8
This appears to be the description of Brineura, a drug used for intraventricular infusions containing cerliponase alfa in a 150mg/5mL dosage stored at 20°C + 5°C. The package contains an Administration Kit and must be used as prescribed. It is advised to store Brineura upright in its original package and thaw at room temperature before use.*
Brineura Vial - brineura 9
This is a label from a pharmaceutical company called BioMarin. It contains information on the administration and dosage of the drug Brineura (cerliponase alfa), which should be used for intraventricular infusion only. It also provides instructions to thaw the drug at room temperature and to use it immediately since it is for single-dose only. The location of the company is in Novato, California, and it is licensed under US License No.1649. The other text seems to be partially corrupted and not-readable.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.